BIOVENTUS INC. Deferred Income Tax Expense (Benefit)
BIOVENTUS INC. (BVS) reported Deferred Income Tax Expense (Benefit) of -$909.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-05
- BIOVENTUS INC. deferred income tax expense (benefit) for the quarter ending 2021-04-03 was $83.00K.
- BIOVENTUS INC. deferred income tax expense (benefit) for the quarter ending 2020-03-28 was -$150.00K.
- BIOVENTUS INC. deferred income tax expense (benefit) for fiscal 2025 was -$909.00K.
- BIOVENTUS INC. deferred income tax expense (benefit) for fiscal 2024 was -$5.39M.
- BIOVENTUS INC. deferred income tax expense (benefit) for fiscal 2023 was -$2.38M.
- BIOVENTUS INC. deferred income tax expense (benefit) for fiscal 2022 was -$46.67M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | -$909.00K 10-K · filed 2026-03-05 | ||
| 2024-12-31 | -$5.39M 10-K · filed 2026-03-05 | ||
| 2023-12-31 | -$2.38M 10-K · filed 2026-03-05 | ||
| 2022-12-31 | -$46.67M 10-K · filed 2025-03-11 | -$52.79M 10-K · filed 2023-03-31 | |
| 2021-12-31 | -$9.76M 10-K · filed 2024-03-12 | ||
| 2021-04-03 | $83.00K 10-Q · filed 2021-05-13 | ||
| 2020-12-31 | -$511.00K 10-K · filed 2023-03-31 | ||
| 2020-03-28 | -$150.00K 10-Q · filed 2021-05-13 | ||
| 2019-12-31 | -$348.00K 10-K · filed 2022-03-11 |